InvestorsHub Logo

Mufaso

04/19/18 4:12 PM

#218618 RE: DewDiligence #218615

RVNC- Todd Zavodnick acknowledged in the investors day presentation that putting together a commercial team now was early by normal standards as you had noted before. He noted you only get one chance to launch and good planning it would help Revance make the right decisions.

I liked the commercial discussion that included the importance of social media, expanding the addressable market of patients and focus on what drives physician practices to be successful.

randychub

04/19/18 6:21 PM

#218625 RE: DewDiligence #218615

I prefer they go after all Botox prove. indications. Rt002 is a better product The risk is less for those indications e


jbog

04/20/18 6:09 AM

#218633 RE: DewDiligence #218615

RVNC expects ~$3B in product and royalty revenue by the end of the next decade,



After a statement like that, my respect for management moves down a few pegs.

I assume they meant Annual, if they are speaking cumulative they might have a shot.